Authors
Latest:
RBM—An Update of Experiences Among European CRAsAn RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.
Latest:
Can Data from EHR Systems Be Trusted in a Trial Setting?An increase in use of EHR systems at clinical investigative sites adds more expectations for clinical trial sponsors to comply by regulatory requirements.
Latest:
Consequences of Brexit for Clinical Trials in EuropeHigher costs headline list of new challenges faced by CROs and sponsors.
Latest:
RBM—An Update of Experiences Among European CRAsAn RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.
Latest:
Cancer Trials: Raising Accrual RatesLessons learned from the recruitment of colorectal cander patients into clinical trials.
Latest:
The Risk Based Monitoring PlanSponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.
Latest:
Strategic Partnerships EvolveGreater product value and innovation accomplished with sponsor-service relationships.
Latest:
Using Data Patterns to Proactively Improve Study QualityRecent analysis showed 81% of clinical trial sites using RBQM statistical data monitoring experienced an improvement in quality.
Latest:
Through the Patient Perspective: Collaborating to Improve Research and DevelopmentAt the October Metrics in Patient Centered Drug Development conference hosted by DIA, many of these key constituents gathered to talk about how to implement and measure the impact of patient input.
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
A Roadmap for Implementing RBM and Quality ManagementThe importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
Barriers and Solutions to Smart Clinical Program DesignsHow the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
Latest:
A Roadmap for Implementing RBM and Quality ManagementThe importance of applying change management techniques throughout the preparation, planning, and execution of RBM and RBQM approaches.
Latest:
Enhancing Obesity Trials with Integrated eCOA and Digital Endpoint TechnologiesWebinar Date/Time: Thursday, June 26th, 2025 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Latest:
Machine Learning within the Clinical Trial ProcessMachine learning technology is finding it’s way into today’s marketplace, specifically within business processes, by driving insurmountable value for corporations within the life science industry, writes Adam Ross Miller.
Latest:
US Clinical Investigator ExperienceThis data analysis takes a look at how much experience US clinical investigators have.
Latest:
Three Steps to A Successful Combination Product TrialSponsors can streamline the design and execution of their clinical trials by following this three-step approach.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.
Latest:
Estimands and Implications for Sponsors as ICH E9 (R1) Addendum ProgressesSponsors should be aware of the significant implications the Addendum is likely to have on clinical trial planning, conduct, statistical analysis, and interpretation.
